David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.52B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$798M |
| 4 |
Amazon
AMZN
|
+$646M |
| 5 |
Texas Instruments
TXN
|
+$619M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.31B |
| 2 |
Broadcom
AVGO
|
+$1.01B |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$863M |
| 4 |
Western Digital
WDC
|
+$595M |
| 5 |
Meta Platforms (Facebook)
META
|
+$591M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.6% |
| 2 | Consumer Discretionary | 9.12% |
| 3 | Healthcare | 7.62% |
| 4 | Industrials | 7.14% |
| 5 | Financials | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
CALL
Global Payments
GPN
$25B
| $519K | ﹤0.01% |
6,700
-20,200
| -75% | -$1.63M |
|
3802
CALL
GE HealthCare
GEHC
$33.4B
| $517K | ﹤0.01% |
+6,300
| New | +$491K |
|
3803
PUT
Phillips 66
PSX
$96B
| $516K | ﹤0.01% |
4,000
-20,900
| -84% | -$2.81M |
|
3804
Cellebrite
CLBT
$2.84B
| $515K | ﹤0.01% |
+28,559
| New | +$513K |
|
3805
IBEX
IBEX
$493M
| $513K | ﹤0.01% |
13,444
-3,631
| -21% | -$134K |
|
3806
CALL
Oxford Industries
OXM
$547M
| $513K | ﹤0.01% |
15,000
| – | – |
|
|
SAFE
3807
Safehold
SAFE
$1.09B
| $513K | ﹤0.01% |
37,443
+16,873
| +82% | +$240K |
|
3808
CALL
Biohaven
BHVN
$2.16B
| $509K | ﹤0.01% |
+45,100
| New | +$559K |
|
|
CIO
3809
DELISTED
City Office REIT
CIO
| $509K | ﹤0.01% |
72,767
-119,591
| -62% | -$828K |
|
3810
Sweetgreen
SG
$827M
| $504K | ﹤0.01% |
74,596
-247,676
| -77% | -$1.7M |
|
3811
CALL
Marathon Petroleum
MPC
$101B
| $504K | ﹤0.01% |
3,100
-21,400
| -87% | -$4M |
|
3812
First Trust Technology AlphaDEX Fund
FXL
$2.72B
| $502K | ﹤0.01% |
2,982
| – | – |
|
3813
Knight Transportation
KNX
$11.3B
| $502K | ﹤0.01% |
9,597
-16,096
| -63% | -$754K |
|
3814
Perella Weinberg Partners
PWP
$1.21B
| $502K | ﹤0.01% |
+28,993
| New | +$541K |
|
3815
Corvus Pharmaceuticals
CRVS
$1.23B
| $500K | ﹤0.01% |
64,915
+39,340
| +154% | +$310K |
|
3816
PUT
Golar LNG
GLNG
$5.26B
| $499K | ﹤0.01% |
13,400
-500
| -4% | -$19.1K |
|
3817
PUT
Motorola Solutions
MSI
$80.4B
| $498K | ﹤0.01% |
+1,300
| New | +$522K |
|
3818
State Street SPDR S&P Capital Markets ETF
KCE
$484M
| $496K | ﹤0.01% |
3,311
| – | – |
|
3819
PUT
Sable Offshore Corp
SOC
$909M
| $496K | ﹤0.01% |
55,000
-1,060,000
| -95% | -$10M |
|
3820
Utah Medical Products
UTMD
$225M
| $494K | ﹤0.01% |
8,835
-346
| -4% | -$20.1K |
|
3821
Hershey
HSY
$37.4B
| $494K | ﹤0.01% |
+2,712
| New | +$496K |
|
3822
Pangaea Logistics
PANL
$541M
| $493K | ﹤0.01% |
71,660
+54,640
| +321% | +$330K |
|
|
BRSL
3823
Brightstar Lottery PLC
BRSL
$2.13B
| $493K | ﹤0.01% |
31,818
-16,924
| -35% | -$276K |
|
|
SOLS
3824
Solstice Advanced Materials
SOLS
$8.8B
| $492K | ﹤0.01% |
+10,130
| New | +$477K |
|
3825
Star Holdings Shares of Beneficial Interest
STHO
$114M
| $489K | ﹤0.01% |
59,442
+25,896
| +77% | +$198K |
|
Similar funds
David Shaw's Q4 2025 Portfolio in Review
As of Q4 2025, David Shaw held 5,141 positions worth $182B, up 3% from $177B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2025 filing shows 639 new, 1,734 increased, 1,574 reduced and 583 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M. The largest sale was Micron Technology, an estimated $1.31B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2025 buy was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M.
- David Shaw added most to Advanced Micro Devices in Q4 2025, an estimated $1.52B increase.
- David Shaw's biggest Q4 2025 reduction was Micron Technology, cutting an estimated $1.31B.
- David Shaw fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2025, selling an estimated $499M.
- David Shaw's ten largest holdings make up 12% of its $182B portfolio in Q4 2025.
- David Shaw opened 639 new positions and closed 583 in Q4 2025.
- David Shaw's portfolio value rose 3% quarter-over-quarter to $182B.
Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.